Knowledge

Autoantibody

Source 📝

71:. Normally, the immune system is able to recognize and ignore the body's own healthy proteins, cells, and tissues, and to not overreact to non-threatening substances in the environment, such as foods. Sometimes, the immune system ceases to recognize one or more of the body's normal constituents as "self", leading to production of pathological autoantibodies. Autoantibodies may also play a nonpathological role; for instance they may help the body to destroy cancers and to eliminate waste products. The role of autoantibodies in normal immune function is also a subject of scientific research. 80:
direct genetic link however. While families may be susceptible to autoimmune conditions, individual family members may have different autoimmune disorders, or may never develop an autoimmune condition. Researchers believe that there may also be a hormonal component as many of the autoimmune conditions are much more prevalent in women of childbearing age. While the initial event that leads to the production of autoantibodies is still unknown, there is a body of evidence that autoantibodies may have the capacity to maintain their production.
115:. Even if they are due to a particular systemic autoimmune condition, the symptoms will vary from person to person, vary over time, vary with organ involvement, and they may taper off or flare unexpectedly. Add to this the fact that a person may have more than one autoantibody, and thus have more than one autoimmune disorder, and/or have an autoimmune disorder without a detectable level of an autoantibody, complicating making a diagnosis. 216:
Antibody profiling is used for identifying persons from forensic samples. The technology can uniquely identify a person by analyzing the antibodies in body fluids. A unique, individual set of antibodies, called individual specific autoantibodies (ISA), is found in blood, serum, saliva, urine, semen,
94:
The type of autoimmune disorder or disease that occurs and the amount of destruction done to the body depends on which systems or organs are targeted by the autoantibodies, and how strongly. Disorders caused by organ specific autoantibodies, those that primarily target a single organ, (such as the
79:
The causes of autoantibody production are varied and not well understood. It is thought that some autoantibody production is due to a genetic predisposition combined with an environmental trigger, such as a viral illness or a prolonged exposure to certain toxic chemicals. There is generally not a
103:), are often the easiest to diagnose as they frequently present with organ related symptoms. Disorders due to systemic autoantibodies can be much more elusive. Although the associated autoimmune disorders are rare, the signs and symptoms they cause are relatively common. Symptoms may include: 118:
The diagnosis of disorders associated with systemic autoantibodies starts with a complete medical history and a thorough physical exam. Based on the patient's signs and symptoms, the doctor may request one or more diagnostic studies that will help to identify a specific disease. As a rule,
177:
Whether a particular autoantibody will be present is both very individual and a matter of statistics. Each will be present in a certain percentage of people who have a particular autoimmune disorder. For instance, up to 80% of those with SLE will have a positive double strand
142:(ANA) test is often ordered first. ANA is a marker of the autoimmune process – it is positive with a variety of different autoimmune diseases but not specific. Consequently, if an ANA test is positive, it is often followed up with other tests associated with arthritis and 182:(anti-dsDNA) autoantibody test, but only about 25–30% will have a positive RNP. Some individuals who do have an autoimmune disorder will have negative autoantibody test results, but at a later date – as the disorder progresses - the autoantibodies may develop. 66:
in two ways: (i) randomly, and (ii) in response to a foreign protein or substance within the body. Initially, one B cell produces one specific kind of antibody. In either case, the B cell is allowed to proliferate or is killed off through a process called
161:
A single autoantibody test is not diagnostic, but may give clues as to whether a particular disorder is likely or unlikely to be present. Each autoantibody result should be considered individually and as part of the group. Some disorders, such as
217:
perspiration, tears, and body tissues, and the antibodies are not affected by illness, medication, or food/drug intake. An unskilled technician using inexpensive equipment can complete a test in a couple of hours.
203:
Monitor the course of the disorder and the effectiveness of treatments. There is no prevention or cure for autoimmune disorders at this time. Treatment is used to alleviate symptoms and to help maintain body
1354:
Itoh S, Ichida T, Yoshida T, et al. (1998). "Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis".
1567:
Kao, A. H.; Lacomis, D.; Lucas, M.; Fertig, N.; Oddis, C. V. (2004). "Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy".
138:
Autoantibody tests may be ordered as part of an investigation of chronic progressive arthritis type symptoms and/or unexplained fevers, fatigue, muscle weakness and rashes. The
119:
information is required from multiple sources, rather than a single laboratory test to accurately diagnose disorders associated with systemic autoantibodies. Tests may include:
1304:"Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis" 1215: 1652: 1684: 648: 107:-type joint pain, fatigue, fever, rashes, cold or allergy-type symptoms, weight loss, and muscular weakness. Associated conditions include 707: 2328: 999: 2125: 1173: 2394: 1677: 1397:
Pedreira S, Sugai E, Moreno ML, et al. (2005). "Significance of smooth muscle/anti-actin autoantibodies in celiac disease".
556: 1424:
Carroccio A, Brusca I, Iacono G, et al. (2007). "IgA anti-actin antibodies ELISA in coeliac disease: A multicentre study".
1197:
Böhm I. Apoptosis: the link between autoantibodies and leuko-/lymphocytopenia in patients. Scand J Rheumatol 2004;33: 409 - 416
949: 886: 861: 1216:
https://inlportal.inl.gov/portal/server.pt/community/idaho_national_laboratory_biological_systems/352/molecular_forensics/2691
1611: 1238: 793: 778: 226:
Note: the sensitivity and specificity of various autoantibodies for a particular disease is different for different diseases.
174:(RNP), is the only one present. Those who have more than one autoimmune disorder may have several detectable autoantibodies. 2278: 1657: 607: 2333: 1670: 1168: 1039: 930: 1206:
Böhm I. Disruption of the cytoskeleton after apoptosis induction by autoantibodies. Autoimmunity 2003;36: 183 - 189
2367: 2307: 2158: 2016: 741: 626: 442: 430: 394: 1630: 1520:"A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis" 1050: 978: 340: 167: 2417: 2195: 2011: 151: 17: 2185: 1954: 1141: 1128: 1044: 915: 772: 495: 362: 197: 2438: 2118: 585: 544: 390: 355: 310: 259: 163: 89: 2323: 2295: 2258: 2250: 2178: 800: 712: 690: 673: 471: 332: 2226: 2210: 1840: 833: 814: 285: 249: 100: 192:
Help determine the degree of organ or system involvement and damage (Along with other tests such as a
2412: 2151: 1518:
Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari A, Coppel R, Podda M, Leung P, Gershwin M (2007).
700: 600: 411: 1662: 2349: 1646: 968: 644: 575: 464: 2215: 1228: 2443: 2372: 2240: 2111: 2020: 1778: 1178: 959: 380: 2042: 1760: 1696: 1260:"Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis" 1154: 482: 2300: 2168: 2142: 1989: 1845: 1823: 964: 945: 514: 423: 418: 325: 179: 1653:
Detection of autoantibodies with self-assembling radiolabeled antigen tetramers (a protocol)
2383: 2006: 1939: 1850: 1774: 1471:"Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays" 1115: 1066: 1023: 666: 563: 549: 528: 367: 244: 193: 139: 1642: 8: 2448: 2354: 2163: 2066: 2001: 1984: 1818: 1736: 984: 902: 865: 570: 401: 51: 278: 263: 1886: 1549: 1495: 1470: 1379: 1333: 1102: 925: 848: 818: 808: 435: 372: 155: 96: 47: 166:(SLE) may be more likely if several autoantibodies are present, while others, such as 2389: 1934: 1700: 1607: 1584: 1541: 1500: 1451: 1406: 1371: 1367: 1325: 1281: 1276: 1259: 1234: 898: 869: 762: 746: 656: 254: 171: 147: 1553: 1469:
Kerkar N, Ma Y, Davies ET, Cheeseman P, Mieli-Vergani G, Vergani D (December 2002).
1383: 1337: 2054: 1994: 1966: 1961: 1929: 1916: 1906: 1576: 1531: 1490: 1482: 1441: 1433: 1363: 1315: 1271: 1004: 661: 2361: 1949: 1320: 1303: 1229:
Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007).
726: 717: 524: 68: 683: 1976: 1921: 1862: 1782: 1755: 881: 731: 532: 452: 406: 295: 220: 1437: 2432: 1944: 1833: 1017: 988: 828: 678: 347: 126:
x-rays and other imaging scans to detect changes in bones, joints, and organs
43: 46:
that is directed against one or more of the individual's own proteins. Many
1911: 1896: 1891: 1726: 1588: 1545: 1504: 1455: 1410: 1080: 843: 756: 695: 595: 143: 1486: 1375: 1329: 1285: 940: 503: 489: 476: 123:
blood tests to detect inflammation, autoantibodies, and organ involvement
2233: 2034: 1787: 1693: 1446: 638: 618: 302: 290: 108: 1580: 1536: 1519: 2269: 2205: 2092: 1797: 1692: 1257: 1089: 1060: 621: 104: 2190: 2082: 1867: 1855: 1813: 1767: 1731: 788: 580: 539: 317: 35: 1636: 2103: 2087: 1901: 1750: 1721: 1026:, paediatric autoimmune neuropsychiatric disease associated with 527:(antibody levels correlate with the level of intestinal damage), 385: 63: 39: 2288: 2283: 2059: 2047: 1792: 1743: 1031: 1008: 633: 612: 112: 519: 1517: 1258:
Wesierska-Gadek J, Hohenuer H, Hitchman E, Penner E (1996).
221:
List of some autoantibodies and commonly associated diseases
1084: 1076: 271: 129:
biopsies to look for pathologic changes in tissue specimens
1301: 2200: 509:
multifocal motor neuropathy with conduction block (MMN)
1468: 1566: 1423: 133: 170:(MCTD) may be more likely if a single autoantibody, 158:(CRP), and/or complement protein|complement levels. 1396: 1302:Szostecki C, Guldner HH, Netter HJ, Will H (1990). 1639:- summaries of research articles + glossary terms 1353: 2430: 872:, subacute sensory neuronopathy, choreathetosis 1174:Reference ranges for blood tests#Autoantibodies 1595: 27:Antibody directed against an autogenic protein 2119: 1678: 1602:Ropper, Allan H.; Samuels, Martin A. (2009). 1601: 1349: 1347: 1297: 1295: 1253: 1251: 649:eosinophilic granulomatosis with polyangiitis 1462: 840:Anti-thyrotropin receptor antibodies (TRAbs) 189:Help diagnose systemic autoimmune disorders. 111:which are inflammation of blood vessels and 1417: 1390: 2126: 2112: 1685: 1671: 1606:(9th ed.). McGraw Hill. p. 656. 1604:Adams and Victor's Principles of Neurology 1344: 1292: 1248: 1645:at the U.S. National Library of Medicine 1535: 1494: 1445: 1319: 1275: 185:Systemic autoantibody tests are used to: 207:Monitor remissions, flares, and relapses 1560: 1221: 1112:basement membrane in lungs and kidneys 1067:neuromyelitis optica (Devic's syndrome) 651:, systemic vasculitides (non-specific) 557:Liver kidney microsomal type 1 antibody 54:) are associated with such antibodies. 14: 2431: 950:paraneoplastic cerebellar degeneration 887:paraneoplastic cerebellar degeneration 862:paraneoplastic cerebellar degeneration 2107: 1666: 1633:Industrial Learning Unit on Chemgaroo 1000:Collapsin response mediator protein 5 825:Anti-thyroglobulin antibodies (TgAbs) 794:small intestinal bacterial overgrowth 470: 211: 608:Anti-neutrophil cytoplasmic antibody 24: 2133: 1169:Anti-glutamate receptor antibodies 1109:Anti-glomerular basement membrane 931:paraneoplastic cerebellar syndrome 134:Indications for autoantibody tests 25: 2460: 1624: 1073:Anti-desmoglein (anti-desmosome) 779:Lambert–Eaton myasthenic syndrome 1368:10.1111/j.1440-1746.1998.01553.x 1277:10.1053/gast.1996.v110.pm8608894 742:nicotinic acetylcholine receptor 627:granulomatosis with polyangiitis 443:Anti-transglutaminase antibodies 431:Anti-glycoprotein-210 antibodies 262:, neonatal heart block, primary 1511: 1148:Anti-phospholipase A2 receptor 1051:anti-NMDA receptor encephalitis 987:, Isaac's Syndrome (autoimmune 979:voltage-gated potassium channel 341:Mixed connective tissue disease 168:mixed connective tissue disease 2012:Immunoglobulin class switching 1631:Autoimmunity – an Introduction 1209: 1200: 1191: 152:erythrocyte sedimentation rate 13: 1: 1184: 1045:N-methyl-D-aspartate receptor 916:opsoclonus myoclonus syndrome 773:voltage-gated calcium channel 496:acute motor axonal neuropathy 363:Anti-topoisomerase antibodies 198:comprehensive metabolic panel 57: 1399:Acta Gastroenterol. Latinoam 1321:10.4049/jimmunol.145.12.4338 684:chronic autoimmune hepatitis 586:systemic lupus erythematosus 545:cyclic citrullinated peptide 260:systemic lupus erythematosus 164:systemic lupus erythematosus 90:Systemic autoimmune diseases 7: 2279:Anti-neutrophil cytoplasmic 2251:Anti-mitochondrial antibody 1426:Digestive and Liver Disease 1162: 801:Anti-thyroid autoantibodies 713:signal recognition particle 691:Anti-mitochondrial antibody 674:Anti-smooth muscle antibody 592:Antiphospholipid antibodies 472:Anti-ganglioside antibodies 83: 62:Antibodies are produced by 10: 2465: 2395:Anti-citrullinated peptide 1841:Polyclonal B cell response 1569:Arthritis & Rheumatism 1233:. Philadelphia: Saunders. 1151:phospholipase A2 receptor 286:Anti-centromere antibodies 250:Anti-SSA/Ro autoantibodies 243: 87: 2405: 2342: 2316: 2267: 2249: 2186:Anti-topoisomerase/Scl-70 2141: 2075: 2033: 1975: 1876: 1806: 1714: 1707: 1438:10.1016/j.dld.2007.06.004 1356:J. Gastroenterol. Hepatol 1147: 1134: 1121: 1108: 1095: 1072: 1056: 1038: 1014: 995: 974: 955: 936: 921: 912:Neuronal nuclear proteins 908: 892: 876: 858:Neuronal nuclear proteins 854: 799: 784: 768: 752: 737: 723: 706: 701:primary biliary cirrhosis 689: 672: 655: 606: 601:antiphospholipid syndrome 591: 555: 538: 513: 441: 412:primary biliary cirrhosis 410: 375:(anti-Scl-70 antibodies) 253: 232: 1647:Medical Subject Headings 969:diabetes mellitus type 1 645:microscopic polyangiitis 576:Anti-thrombin antibodies 465:dermatitis herpetiformis 180:anti-double stranded DNA 74: 2308:Anti-TPO/Antimicrosomal 1231:Robbins Basic Pathology 1179:Paraneoplastic syndrome 1125:gastric parietal cells 960:Glutamate decarboxylase 834:Hashimoto's thyroiditis 815:Hashimoto's thyroiditis 381:Anti-histone antibodies 101:Hashimoto's thyroiditis 1955:Tolerance in pregnancy 1697:adaptive immune system 1155:Membranous nephropathy 1135:Anti-intrinsic factor 757:Muscle-specific kinase 483:Miller Fisher syndrome 245:Antinuclear antibodies 2368:Anti-transglutaminase 2143:Anti-nuclear antibody 1990:Somatic hypermutation 1824:Polyclonal antibodies 1819:Monoclonal antibodies 1487:10.1136/jcp.55.12.906 965:stiff person syndrome 946:stiff person syndrome 515:Anti-actin antibodies 424:Sp100 nuclear antigen 419:Anti-sp100 antibodies 326:inflammatory myopathy 322:histidine-tRNA ligase 88:Further information: 2007:Junctional diversity 1775:Antigen presentation 1116:Goodpasture syndrome 667:rheumatoid arthritis 564:autoimmune hepatitis 550:rheumatoid arthritis 529:autoimmune hepatitis 368:Type I topoisomerase 194:complete blood count 140:antinuclear antibody 2439:Autoimmune diseases 2418:Anti-apolipoprotein 2355:Lupus anticoagulant 2002:V(D)J recombination 1985:Affinity maturation 1737:Antigenic variation 1122:Anti-parietal cell 1096:Anti-hemidesmosome 985:limbic encephalitis 903:limbic encephalitis 866:limbic encephalitis 805:Anti-TPO antibodies 571:Lupus anticoagulant 402:Anti-p62 antibodies 352:snRNP core proteins 307:double-stranded DNA 172:ribonucleic protein 52:lupus erythematosus 48:autoimmune diseases 2406:Multiple locations 2296:Anti-smooth muscle 1103:Bullous pemphigoid 1090:Pemphigus vulgaris 926:glutamate receptor 809:Thyroid peroxidase 436:nucleoporin 210kDa 373:systemic sclerosis 255:ribonucleoproteins 212:Antibody profiling 156:c-reactive protein 42:) produced by the 2426: 2425: 2413:Anti-phospholipid 2390:Rheumatoid factor 2101: 2100: 2029: 2028: 1779:professional APCs 1613:978-0-07-149992-7 1581:10.1002/art.11484 1537:10.1002/hep.21583 1240:978-1-4160-2973-1 1160: 1159: 1142:Pernicious anemia 1138:intrinsic factor 1129:Pernicious anemia 1024:Sydenham's chorea 899:encephalomyelitis 870:encephalomyelitis 763:myasthenia gravis 747:myasthenia gravis 657:Rheumatoid factor 337:Ribonucleoprotein 148:rheumatoid factor 16:(Redirected from 2456: 2375:not autoantibody 2324:Anti-ganglioside 2259:Anti-cardiolipin 2128: 2121: 2114: 2105: 2104: 1995:Clonal selection 1967:Immune privilege 1962:Immunodeficiency 1917:Cross-reactivity 1907:Hypersensitivity 1712: 1711: 1687: 1680: 1673: 1664: 1663: 1658:Antibody Sensors 1637:Autoimmunityblog 1618: 1617: 1599: 1593: 1592: 1564: 1558: 1557: 1539: 1515: 1509: 1508: 1498: 1466: 1460: 1459: 1449: 1421: 1415: 1414: 1394: 1388: 1387: 1351: 1342: 1341: 1323: 1299: 1290: 1289: 1279: 1264:Gastroenterology 1255: 1246: 1244: 1225: 1219: 1218:Antibody Sensors 1213: 1207: 1204: 1198: 1195: 1083:) and sometimes 1005:optic neuropathy 937:Anti-amphiphysin 909:Anti-Ri (ANNA-2) 855:Anti-Hu (ANNA-1) 279:Sjögren syndrome 264:Sjögren syndrome 230: 229: 21: 2464: 2463: 2459: 2458: 2457: 2455: 2454: 2453: 2429: 2428: 2427: 2422: 2401: 2362:Coeliac disease 2338: 2312: 2263: 2245: 2227:Anti-centromere 2137: 2132: 2102: 2097: 2071: 2025: 1971: 1950:Clonal deletion 1878: 1872: 1802: 1703: 1691: 1627: 1622: 1621: 1614: 1600: 1596: 1565: 1561: 1516: 1512: 1475:J. Clin. Pathol 1467: 1463: 1422: 1418: 1395: 1391: 1352: 1345: 1314:(12): 4338–47. 1300: 1293: 1256: 1249: 1241: 1226: 1222: 1214: 1210: 1205: 1201: 1196: 1192: 1187: 1165: 1099:hemidesmosomes 849:Graves' disease 819:Graves' disease 727:exosome complex 718:dermatomyositis 525:Coeliac disease 395:drug-induced LE 236:Antibody target 223: 214: 136: 97:Graves' disease 92: 86: 77: 69:clonal deletion 60: 28: 23: 22: 15: 12: 11: 5: 2462: 2452: 2451: 2446: 2444:Autoantibodies 2441: 2424: 2423: 2421: 2420: 2415: 2409: 2407: 2403: 2402: 2400: 2399: 2398: 2397: 2392: 2379: 2378: 2377: 2376: 2370: 2358: 2357: 2352: 2346: 2344: 2340: 2339: 2337: 2336: 2334:Anti-glutamate 2331: 2326: 2320: 2318: 2314: 2313: 2311: 2310: 2305: 2304: 2303: 2293: 2292: 2291: 2286: 2275: 2273: 2265: 2264: 2262: 2261: 2255: 2253: 2247: 2246: 2244: 2243: 2237: 2236: 2230: 2229: 2223: 2222: 2221: 2220: 2219: 2218: 2213: 2208: 2203: 2193: 2188: 2174: 2173: 2172: 2171: 2166: 2161: 2147: 2145: 2139: 2138: 2135:Autoantibodies 2131: 2130: 2123: 2116: 2108: 2099: 2098: 2096: 2095: 2090: 2085: 2079: 2077: 2073: 2072: 2070: 2069: 2064: 2063: 2062: 2052: 2051: 2050: 2039: 2037: 2031: 2030: 2027: 2026: 2024: 2023: 2014: 2009: 2004: 1999: 1998: 1997: 1992: 1981: 1979: 1977:Immunogenetics 1973: 1972: 1970: 1969: 1964: 1959: 1958: 1957: 1952: 1947: 1942: 1937: 1925: 1924: 1922:Co-stimulation 1919: 1914: 1909: 1904: 1899: 1894: 1889: 1882: 1880: 1874: 1873: 1871: 1870: 1865: 1863:Immune complex 1859: 1858: 1853: 1848: 1843: 1838: 1837: 1836: 1831: 1826: 1821: 1810: 1808: 1804: 1803: 1801: 1800: 1795: 1790: 1785: 1783:Dendritic cell 1771: 1770: 1765: 1764: 1763: 1761:Conformational 1758: 1747: 1746: 1741: 1740: 1739: 1734: 1729: 1718: 1716: 1709: 1705: 1704: 1690: 1689: 1682: 1675: 1667: 1661: 1660: 1655: 1650: 1643:Autoantibodies 1640: 1634: 1626: 1625:External links 1623: 1620: 1619: 1612: 1594: 1575:(1): 209–215. 1559: 1510: 1461: 1416: 1389: 1343: 1291: 1247: 1239: 1227:Table 5-9 in: 1220: 1208: 1199: 1189: 1188: 1186: 1183: 1182: 1181: 1176: 1171: 1164: 1161: 1158: 1157: 1152: 1149: 1145: 1144: 1139: 1136: 1132: 1131: 1126: 1123: 1119: 1118: 1113: 1110: 1106: 1105: 1100: 1097: 1093: 1092: 1087: 1074: 1070: 1069: 1064: 1058: 1054: 1053: 1048: 1042: 1036: 1035: 1021: 1015: 1012: 1011: 1002: 997: 993: 992: 982: 976: 972: 971: 962: 957: 953: 952: 943: 938: 934: 933: 928: 923: 919: 918: 913: 910: 906: 905: 896: 894: 890: 889: 884: 882:Purkinje cells 878: 874: 873: 859: 856: 852: 851: 846: 841: 837: 836: 831: 826: 822: 821: 812: 806: 803: 797: 796: 791: 786: 782: 781: 776: 770: 766: 765: 760: 754: 750: 749: 744: 739: 735: 734: 732:scleromyositis 729: 724: 721: 720: 715: 710: 704: 703: 698: 693: 687: 686: 681: 676: 670: 669: 664: 659: 653: 652: 642: 636: 630: 629: 624: 615: 610: 604: 603: 598: 593: 589: 588: 583: 578: 573: 567: 566: 561: 559: 553: 552: 547: 542: 536: 535: 533:gastric cancer 522: 517: 511: 510: 507: 500: 499: 493: 486: 485: 480: 474: 468: 467: 462: 460: 456: 455: 453:celiac disease 450: 448: 445: 439: 438: 433: 427: 426: 421: 415: 414: 409: 407:nucleoporin 62 404: 398: 397: 388: 383: 377: 376: 370: 365: 359: 358: 353: 350: 344: 343: 338: 335: 329: 328: 323: 320: 314: 313: 308: 305: 299: 298: 296:CREST syndrome 293: 288: 282: 281: 275: 274:autoantibodies 267: 266: 257: 252: 247: 241: 240: 237: 234: 222: 219: 213: 210: 209: 208: 205: 201: 190: 135: 132: 131: 130: 127: 124: 85: 82: 76: 73: 59: 56: 26: 18:Autoantibodies 9: 6: 4: 3: 2: 2461: 2450: 2447: 2445: 2442: 2440: 2437: 2436: 2434: 2419: 2416: 2414: 2411: 2410: 2408: 2404: 2396: 2393: 2391: 2388: 2387: 2386: 2385: 2381: 2380: 2374: 2371: 2369: 2366: 2365: 2363: 2360: 2359: 2356: 2353: 2351: 2350:Anti-thrombin 2348: 2347: 2345: 2343:Extracellular 2341: 2335: 2332: 2330: 2327: 2325: 2322: 2321: 2319: 2317:Cell membrane 2315: 2309: 2306: 2302: 2299: 2298: 2297: 2294: 2290: 2287: 2285: 2282: 2281: 2280: 2277: 2276: 2274: 2271: 2266: 2260: 2257: 2256: 2254: 2252: 2248: 2242: 2239: 2238: 2235: 2232: 2231: 2228: 2225: 2224: 2217: 2214: 2212: 2209: 2207: 2204: 2202: 2199: 2198: 2197: 2194: 2192: 2189: 2187: 2184: 2183: 2182: 2180: 2176: 2175: 2170: 2167: 2165: 2162: 2160: 2157: 2156: 2155: 2153: 2149: 2148: 2146: 2144: 2140: 2136: 2129: 2124: 2122: 2117: 2115: 2110: 2109: 2106: 2094: 2091: 2089: 2086: 2084: 2081: 2080: 2078: 2074: 2068: 2065: 2061: 2058: 2057: 2056: 2053: 2049: 2046: 2045: 2044: 2041: 2040: 2038: 2036: 2032: 2022: 2018: 2015: 2013: 2010: 2008: 2005: 2003: 2000: 1996: 1993: 1991: 1988: 1987: 1986: 1983: 1982: 1980: 1978: 1974: 1968: 1965: 1963: 1960: 1956: 1953: 1951: 1948: 1946: 1945:Clonal anergy 1943: 1941: 1938: 1936: 1933: 1932: 1931: 1927: 1926: 1923: 1920: 1918: 1915: 1913: 1910: 1908: 1905: 1903: 1900: 1898: 1895: 1893: 1890: 1888: 1884: 1883: 1881: 1875: 1869: 1866: 1864: 1861: 1860: 1857: 1854: 1852: 1849: 1847: 1844: 1842: 1839: 1835: 1834:Microantibody 1832: 1830: 1827: 1825: 1822: 1820: 1817: 1816: 1815: 1812: 1811: 1809: 1805: 1799: 1796: 1794: 1791: 1789: 1786: 1784: 1780: 1776: 1773: 1772: 1769: 1766: 1762: 1759: 1757: 1754: 1753: 1752: 1749: 1748: 1745: 1742: 1738: 1735: 1733: 1730: 1728: 1725: 1724: 1723: 1720: 1719: 1717: 1713: 1710: 1706: 1702: 1698: 1695: 1688: 1683: 1681: 1676: 1674: 1669: 1668: 1665: 1659: 1656: 1654: 1651: 1648: 1644: 1641: 1638: 1635: 1632: 1629: 1628: 1615: 1609: 1605: 1598: 1590: 1586: 1582: 1578: 1574: 1570: 1563: 1555: 1551: 1547: 1543: 1538: 1533: 1530:(3): 659–65. 1529: 1525: 1521: 1514: 1506: 1502: 1497: 1492: 1488: 1484: 1481:(12): 906–9. 1480: 1476: 1472: 1465: 1457: 1453: 1448: 1443: 1439: 1435: 1432:(9): 818–23. 1431: 1427: 1420: 1412: 1408: 1404: 1400: 1393: 1385: 1381: 1377: 1373: 1369: 1365: 1362:(3): 257–65. 1361: 1357: 1350: 1348: 1339: 1335: 1331: 1327: 1322: 1317: 1313: 1309: 1305: 1298: 1296: 1287: 1283: 1278: 1273: 1269: 1265: 1261: 1254: 1252: 1242: 1236: 1232: 1224: 1217: 1212: 1203: 1194: 1190: 1180: 1177: 1175: 1172: 1170: 1167: 1166: 1156: 1153: 1150: 1146: 1143: 1140: 1137: 1133: 1130: 1127: 1124: 1120: 1117: 1114: 1111: 1107: 1104: 1101: 1098: 1094: 1091: 1088: 1086: 1082: 1078: 1075: 1071: 1068: 1065: 1062: 1059: 1055: 1052: 1049: 1046: 1043: 1041: 1037: 1033: 1029: 1028:Streptococcus 1025: 1022: 1019: 1018:basal ganglia 1016: 1013: 1010: 1006: 1003: 1001: 998: 994: 990: 989:neuromyotonia 986: 983: 980: 977: 973: 970: 966: 963: 961: 958: 954: 951: 947: 944: 942: 939: 935: 932: 929: 927: 924: 920: 917: 914: 911: 907: 904: 900: 897: 895: 891: 888: 885: 883: 879: 875: 871: 867: 863: 860: 857: 853: 850: 847: 845: 842: 839: 838: 835: 832: 830: 829:Thyroglobulin 827: 824: 823: 820: 816: 813: 810: 807: 804: 802: 798: 795: 792: 790: 787: 785:Anti-Vinculin 783: 780: 777: 774: 771: 767: 764: 761: 758: 755: 751: 748: 745: 743: 740: 736: 733: 730: 728: 725: 722: 719: 716: 714: 711: 709: 705: 702: 699: 697: 694: 692: 688: 685: 682: 680: 679:smooth muscle 677: 675: 671: 668: 665: 663: 660: 658: 654: 650: 646: 643: 640: 637: 635: 632: 631: 628: 625: 623: 620: 616: 614: 611: 609: 605: 602: 599: 597: 594: 590: 587: 584: 582: 579: 577: 574: 572: 569: 568: 565: 562: 560: 558: 554: 551: 548: 546: 543: 541: 537: 534: 530: 526: 523: 521: 518: 516: 512: 508: 505: 502: 501: 497: 494: 491: 488: 487: 484: 481: 478: 475: 473: 469: 466: 463: 461: 458: 457: 454: 451: 449: 446: 444: 440: 437: 434: 432: 429: 428: 425: 422: 420: 417: 416: 413: 408: 405: 403: 400: 399: 396: 392: 389: 387: 384: 382: 379: 378: 374: 371: 369: 366: 364: 361: 360: 357: 354: 351: 349: 346: 345: 342: 339: 336: 334: 331: 330: 327: 324: 321: 319: 316: 315: 312: 309: 306: 304: 301: 300: 297: 294: 292: 289: 287: 284: 283: 280: 276: 273: 269: 268: 265: 261: 258: 256: 251: 248: 246: 242: 238: 235: 231: 228: 227: 218: 206: 202: 199: 195: 191: 188: 187: 186: 183: 181: 175: 173: 169: 165: 159: 157: 153: 149: 145: 141: 128: 125: 122: 121: 120: 116: 114: 110: 106: 102: 98: 91: 81: 72: 70: 65: 55: 53: 49: 45: 44:immune system 41: 37: 33: 19: 2382: 2373:Anti-gliadin 2241:Anti-histone 2177: 2150: 2134: 1912:Inflammation 1897:Alloimmunity 1892:Autoimmunity 1877:Immunity vs. 1829:Autoantibody 1828: 1727:Superantigen 1603: 1597: 1572: 1568: 1562: 1527: 1523: 1513: 1478: 1474: 1464: 1429: 1425: 1419: 1405:(2): 83–93. 1402: 1398: 1392: 1359: 1355: 1311: 1307: 1270:(3): 840–7. 1267: 1263: 1245:8th edition. 1230: 1223: 1211: 1202: 1193: 1081:Desmoglein 3 1057:NMO antibody 1027: 844:TSH receptor 811:(microsomal) 696:mitochondria 617:proteins in 596:phospholipid 233:Autoantibody 225: 224: 215: 184: 176: 160: 146:, such as a 144:inflammation 137: 117: 93: 78: 61: 32:autoantibody 31: 29: 2035:Lymphocytes 1694:Lymphocytic 1447:10447/34417 996:Anti-CRMP-5 941:amphiphysin 880:Cerebellar 641:perinuclear 504:ganglioside 490:ganglioside 477:ganglioside 95:thyroid in 38:(a type of 2449:Antibodies 2433:Categories 2301:Anti-actin 2234:Anti-dsDNA 2169:Anti-sp100 2159:Anti-gp210 2076:Substances 1940:Peripheral 1928:Inaction: 1807:Antibodies 1788:Macrophage 1701:complement 1524:Hepatology 1308:J. Immunol 1185:References 1040:Anti-NMDAr 775:(P/Q-type) 639:neutrophil 619:neutrophil 348:Anti-Smith 303:Anti-dsDNA 291:centromere 239:Condition 109:vasculitis 58:Production 2270:cytoplasm 2206:Anti-nRNP 2093:Cytolysin 2083:Cytokines 1930:Tolerance 1879:tolerance 1798:Immunogen 1061:aquaporin 975:Anti-VGKC 769:Anti-VGCC 753:Anti-MUSK 738:Anti-AChR 622:cytoplasm 204:function. 154:(ESR), a 150:(RF), an 105:arthritis 50:(notably 2329:Anti-GBM 2272:antibody 2191:Anti-Jo1 2164:Anti-p62 2043:Cellular 1887:Immunity 1885:Action: 1868:Paratope 1856:Idiotype 1846:Allotype 1814:Antibody 1768:Mimotope 1732:Allergen 1715:Antigens 1708:Lymphoid 1589:14730618 1554:19227989 1546:17326160 1505:12461054 1456:17652043 1411:16127984 1384:73008610 1338:43572051 1163:See also 956:Anti-GAD 789:vinculin 708:Anti-SRP 581:thrombin 540:anti-CCP 459:Anti-eTG 447:Anti-tTG 386:histones 333:Anti-RNP 318:Anti-Jo1 277:Primary 270:Anti-La/ 84:Diseases 36:antibody 2216:Anti-La 2211:Anti-Ro 2201:Anti-Sm 2088:Opsonin 2067:NK cell 2055:Humoral 1935:Central 1902:Allergy 1851:Isotype 1751:Epitope 1722:Antigen 1496:1769836 1376:9570238 1330:2258622 1286:8608894 1020:neurons 922:Anti-Tr 893:Anti-Ma 877:Anti-Yo 498:(AMAN) 64:B cells 40:protein 2289:P-ANCA 2284:C-ANCA 2060:B cell 2048:T cell 1793:B cell 1756:Linear 1744:Hapten 1649:(MeSH) 1610:  1587:  1552:  1544:  1503:  1493:  1454:  1409:  1382:  1374:  1336:  1328:  1284:  1237:  1047:(NMDA) 1032:PANDAS 1009:chorea 981:(VGKC) 759:(MUSK) 634:p-ANCA 613:c-ANCA 113:anemia 34:is an 2268:Anti- 1550:S2CID 1380:S2CID 1334:S2CID 520:actin 75:Cause 2196:ENA4 1699:and 1608:ISBN 1585:PMID 1542:PMID 1501:PMID 1452:PMID 1407:PMID 1372:PMID 1326:PMID 1282:PMID 1235:ISBN 1085:Dsg1 1077:Dsg3 479:GQ1B 393:and 272:SS-B 99:and 2179:ENA 2152:PBC 2021:HLA 2017:MHC 1577:doi 1532:doi 1491:PMC 1483:doi 1442:hdl 1434:doi 1364:doi 1316:doi 1312:145 1272:doi 1268:110 662:IgG 506:GM1 492:GD3 391:SLE 356:SLE 311:SLE 196:or 30:An 2435:: 2384:RA 2364:: 1781:: 1583:. 1573:50 1571:. 1548:. 1540:. 1528:45 1526:. 1522:. 1499:. 1489:. 1479:55 1477:. 1473:. 1450:. 1440:. 1430:39 1428:. 1403:35 1401:. 1378:. 1370:. 1360:13 1358:. 1346:^ 1332:. 1324:. 1310:. 1306:. 1294:^ 1280:. 1266:. 1262:. 1250:^ 1063:-4 1034:) 1007:, 991:) 967:, 948:, 901:, 868:, 864:, 817:, 647:, 531:, 2181:: 2154:: 2127:e 2120:t 2113:v 2019:/ 1777:/ 1686:e 1679:t 1672:v 1616:. 1591:. 1579:: 1556:. 1534:: 1507:. 1485:: 1458:. 1444:: 1436:: 1413:. 1386:. 1366:: 1340:. 1318:: 1288:. 1274:: 1243:. 1079:( 1030:( 200:) 20:)

Index

Autoantibodies
antibody
protein
immune system
autoimmune diseases
lupus erythematosus
B cells
clonal deletion
Systemic autoimmune diseases
Graves' disease
Hashimoto's thyroiditis
arthritis
vasculitis
anemia
antinuclear antibody
inflammation
rheumatoid factor
erythrocyte sedimentation rate
c-reactive protein
systemic lupus erythematosus
mixed connective tissue disease
ribonucleic protein
anti-double stranded DNA
complete blood count
comprehensive metabolic panel
Antinuclear antibodies
Anti-SSA/Ro autoantibodies
ribonucleoproteins
systemic lupus erythematosus
Sjögren syndrome

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.